Kewaunee Scientific Corporation

NasdaqGM:KEQU Stock Report

Market Cap: US$103.4m

Kewaunee Scientific Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Kewaunee Scientific.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth16.2%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Dec 18
Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Jul 02
Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Mar 10
Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M

Sep 08

Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M

Jun 30

Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Apr 12
Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

Dec 28
Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

Kewaunee Scientific reports Q2 results

Dec 09

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Kewaunee Scientific has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NasdaqGM:KEQU - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
1/31/202420191218N/A
10/31/2023215706N/A
7/31/20232194-51N/A
4/30/20232191-8-4N/A
1/31/2023215-1-13-10N/A
10/31/2022195-3-4-2N/A
7/31/2022180-6-4-2N/A
4/30/2022169-6-10-8N/A
1/31/2022158-9-5-3N/A
10/31/2021151-7-7-5N/A
7/31/2021151-402N/A
4/30/2021147-4-11N/A
1/31/2021143-203N/A
10/31/2020144-4-4-1N/A
7/31/2020145-6-11N/A
4/30/2020148-524N/A
1/31/2020148-5-13N/A
10/31/2019146-315N/A
7/31/2019144105N/A
4/30/20191472-22N/A
1/31/2019156458N/A
10/31/2018162548N/A
7/31/20181666-40N/A
4/30/2018158503N/A
1/31/2018148535N/A
10/31/20171405N/A7N/A
7/31/20171354N/A12N/A
4/30/20171395N/A12N/A
1/31/20171384N/A10N/A
10/31/20161405N/A8N/A
7/31/20161354N/A6N/A
4/30/20161294N/A7N/A
1/31/20161253N/A-1N/A
10/31/20151203N/A-3N/A
7/31/20151193N/A4N/A
4/30/20151194N/A2N/A
1/31/20151164N/A7N/A
10/31/20141144N/A9N/A
7/31/20141104N/A6N/A
4/30/20141114N/A8N/A
1/31/20141164N/A6N/A
10/31/20131174N/A8N/A
7/31/20131224N/A3N/A
4/30/20131173N/A4N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if KEQU's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if KEQU's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if KEQU's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if KEQU's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if KEQU's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if KEQU's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.